Search company, investor...

Food and Drug Analytical Services

fdas.org

Stage

Acquired | Acquired

About Food and Drug Analytical Services

Food and Drug Analytical Services is an independent provider of pharmaceutical QC testing in the UK. The company covers a wide range of Raw Materials, API's, Finished Products. Water testing, (Pharmaceutical & NHS waters to HTM guidelines). FDAS offers a range of food, drug and health-sector testing services within an accredited laboratory in a facility helping clients achieve quality control objectives quickly and efficiently. Founded in 2004, FDAS offers a full contract testing service – incorporating chemistry, microbiology, stability and development capabilities – to some of the UK's largest pharmaceutical companies.

Headquarters Location

Pennyfoot Street

Nottingham, England, NG1 1GF,

United Kingdom

0115 912 4210

Missing: Food and Drug Analytical Services's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Food and Drug Analytical Services's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Food and Drug Analytical Services News

Catapult exits Food and Drug Analytical Services

Apr 7, 2016

7 April 2016 5th April 2016 - Catapult Venture Managers Limited (“Catapult”) is delighted to announce that its portfolio business, Food and Drug Analytical Services Limited (‘’FDAS’’) has been acquired by Tentamus UK Limited, the UK subsidiary of German laboratories group Tentamus Group GmbH. Based at BioCity, Nottingham, FDAS is one of the UK’s leading independent providers of pharmaceutical quality control testing services. Catapult first invested in the company when it was formed in 2004, alongside the founders of the business. Accredited by the Medicines & Healthcare Products Regulatory Agency (MHRA), FDAS delivers a full contract testing service – incorporating chemistry, microbiology, stability and development capabilities - to some of the UK’s largest pharmaceutical companies. The sale provides another highly satisfactory exit for Catapult’s East Midlands Regional Venture Capital Fund (‘EMRVCF’). Occupying state of the art laboratory facilities, the investment has enabled FDAS to significantly grow its market share and turnover, and to cement an exceptional reputation in the industry. The company has also steadily invested in additional equipment and staff and now employs in excess of 20 people. Jonathan Lowe, Head of Investor Relations at Catapult, said, “Under Larissa Taylor’s leadership, FDAS has developed into a highly successful business, undertaking important testing work for the benefit of customers and consumers alike. Since we first invested in 2004, we have worked closely with the Board and management team of the company to support its growth and we are very proud of the success of the business to date. We are sure that under its new owners, FDAS will continue to go from strength to strength.’’ Larissa Taylor, Technical Director at FDAS said “The sale of FDAS to Tentamus is without doubt the best option for the company and represents the next phase of development and growth. As part of the Tentamus Group of companies we will continue to build on our success. Part of the reason for that success has been the investment and support that Catapult have provided over the last twelve years, which has been greatly appreciated by the management team.’’ With Larissa Taylor continuing to lead the business, the transition is expected to be seamless for staff and customers with no disruption to operations. Shareholders were advised by the corporate team at Nottingham-based law firm Fraser Brown, led by Tom Gray and assisted by Peter Abel with accounting advice from Smith Hodge and Baxter.

Food and Drug Analytical Services Frequently Asked Questions (FAQ)

  • Where is Food and Drug Analytical Services's headquarters?

    Food and Drug Analytical Services's headquarters is located at Pennyfoot Street, Nottingham.

  • What is Food and Drug Analytical Services's latest funding round?

    Food and Drug Analytical Services's latest funding round is Acquired.

  • Who are the investors of Food and Drug Analytical Services?

    Investors of Food and Drug Analytical Services include Tentamus Group, East Midlands Early Growth Fund, E-Synergy and Catapult.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.